NCT07305922 Delayed Cerebral Infarction Beyond Endoluminal Spasmolysis and Induced Hypertension
| NCT ID | NCT07305922 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Region Stockholm |
| Condition | Subarachnoid Aneurysm Hemorrhage |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2025-12-01 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
An observational study of patients with emerging or established severe cerebral vasospasm after subarachnoid haemorrhage, employing multimodal neuromonitoring.
Eligibility Criteria
Inclusion Criteria: * Adults 18 years or older * Critical care after subarachnoid haemorrhage * Aneurysm secured by surgical clipping or endovascular procedure * Suspected, emerging or established severe cerebral vasospasm Exclusion Criteria: * Anticipated survival less than five days, as determined by treating clinician * Transcranial Doppler signal too weak * Pregnancy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07305922 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Subarachnoid Aneurysm Hemorrhage. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07305922 currently recruiting?
Yes, NCT07305922 is actively recruiting participants. Contact the research team at peter.rudberg@ki.se for enrollment information.
Where is the NCT07305922 trial being conducted?
This trial is being conducted at Stockholm, Sweden.
Who is sponsoring the NCT07305922 clinical trial?
NCT07305922 is sponsored by Region Stockholm. The trial plans to enroll 200 participants.